Magtrace®

A simple solution for breast cancer staging

Iron oxide. Sugar. Salt. Water. Four simple ingredients that together provide a safe and flexible way to stage early breast cancer.

Particles optimized for nodes

The tiny particles are optimized for migration and uptake in the lymph nodes, providing a clear signal as well as visual guidance when performing sentinel node biopsy procedures.

Everything you need. Any time you need it.

Magtrace® is a single injection, dual-tracer that works in minutes. It remains in the sentinel lymph nodes for at least a month, so you can plan injections to suit you and your patient.

Put patient comfort first

Eliminate patient pain by injecting Magtrace® in the OR after anesthesia for mastectomy. If injected days before surgery, Magtrace can cause less discomfort than radioactive isotopes.

No benefit? No surgery. No brainer.

Up to 80% of high-risk DCIS patients can avoid unnecessary lymph node surgery with Magtrace®. With its 30-day detection window, you only need to proceed with axillary surgery once pathology confirms there’s a benefit.

Particles optimized for nodes

The tiny particles are optimized for migration and uptake in the lymph nodes, providing a clear signal as well as visual guidance when performing sentinel node biopsy procedures.

Everything you need. Any time you need it.

Magtrace® is a single injection, dual-tracer that works in minutes. It remains in the sentinel lymph nodes for at least a month, so you can plan injections to suit you and your patient.

Put patient comfort first

Eliminate patient pain by injecting Magtrace® in the OR after anesthesia for mastectomy. If injected days before surgery, Magtrace can cause less discomfort than radioactive isotopes.

No benefit? No surgery. No brainer.

Up to 80% of high-risk DCIS patients can avoid unnecessary lymph node surgery with Magtrace®. With its 30-day detection window, you only need to proceed with axillary surgery once pathology confirms there’s a benefit.

Seed plus tracer, working in harmony

Use Magtrace® alongside Magseed Pro®* for targeted axillary lymph node dissection. The Sentimag® system can isolate either signal, making tissue localization and axillary staging easier than ever before.

*Magseed Pro not yet available for commercial sale

Why magnetic tracers?

Magnetic tracers have been designed to simplify breast cancer staging, to make it more convenient, more widely available and never compromising on clinical effectiveness.

  • Accurate

    Clinical trials have shown Magtrace® to be non-inferior to the combination of radioisotope +/- blue dyes.

  • Safe

    No reported allergic reactions or anaphylaxis in over 100,000 cases.

  • Flexible

    Inject up to days or weeks prior to surgery without compromising the efficacy or accuracy.

  • Radiation-free

    Iron oxide. Sugar. Salt. Water. A simple solution to replace radioactive tracers.

Trusted by experts, demanded by patients

Hear how world-leading physicians are enjoying the truly unique benefits of the Magtrace® lymphatic tracer to provide a more flexible approach to SLNB and avoid surgery when it’s not needed.

Janette Gomez, DO Allegheny Health Network
Kristen Williams, MD Baptist Health Paducah
Anne Peled, MD Sutter Health
Lucy De La Cruz, MD MedStar Georgetown University Hospital
Tammy De La Melena, MD Compass Oncology
Kelly Hewitt, MD Vanderbilt
Janette Gomez, DO Allegheny Health Network
Kristen Williams, MD Baptist Health Paducah
Anne Peled, MD Sutter Health
Lucy De La Cruz, MD MedStar Georgetown University Hospital
Tammy De La Melena, MD Compass Oncology
Kelly Hewitt, MD Vanderbilt
Magtrace is a real game-changer to the way we treat breast cancer in the United States.
Laura Esserman, MD CSF Breast Care Center
It's life changing for the patient and practice changing for us. It does a great job.
Lucy De La Cruz, MD MedStar Georgetown University Hospital
Given enough time and dispersement of this information and technology, Delayed Sentinel Node Biopsy will become a standard.
Shawna Willey, MD Inova Schar Cancer Institute
This is the one product I've seen that provides a real benefit to the patient that is substantial.
Janette Gomez, DO Allegheny General Hospital
Magtrace is a real game-changer to the way we treat breast cancer in the United States.
Laura Esserman, MD CSF Breast Care Center
It's life changing for the patient and practice changing for us. It does a great job.
Lucy De La Cruz, MD MedStar Georgetown University Hospital
Given enough time and dispersement of this information and technology, Delayed Sentinel Node Biopsy will become a standard.
Shawna Willey, MD Inova Schar Cancer Institute
This is the one product I've seen that provides a real benefit to the patient that is substantial.
Janette Gomez, DO Allegheny General Hospital

Backed by data

150,000+

total patients treated

98.2%

sentinel lymph node detection rate

93.4%

nodal malignancy detection per patient

95.5%

nodal detection rate

2.3

average nodes obtained per patient

Related Products

Get started with your Magtrace® trial

Give your patients a better standard of breast cancer surgery without the need for radioactivity. Set up a Magtrace® lymphatic tracer evaluation today.

  • Evaluate Magtrace®
  • 150,000+ patients already treated
Arrange your Magtrace trial